Dupilumab: The First Approved Biologic for Atopic Dermatitis

Time: 3:20 pm
day: Day Two

Details:

  • Shining light on the rationale for biologic development during a wave of JAK inhibitor development
  • Transforming quality of life for patients by tackling chronic itch
  • Looking forward into bringing dupilumab into other dermatological indications

Speakers: